Evidence map›Paper›PMID 39897194›Full record

ArticleCureus2025

Dreaded Degos Disease in Childhood.

Murugan Sundaram, Nishantan Thamotharan, Adikrishnan Swaminathan, Sudha Rangarajan, Krishnakanth Muralidhar

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Murugan SundaramDermatology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Nishantan ThamotharanDermatology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Adikrishnan SwaminathanDermatology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Sudha RangarajanDermatology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Krishnakanth MuralidharDermatology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Degos disease or malignant atrophic papulosis is a rare multisystem vascular disease of unknown etiology most commonly affecting the small- to medium-sized arteries of the dermis of the skin, gastrointestinal tract, and central nervous system. Endothelial cell damage and the activation of the coagulation cascade leading to the obliterative thrombosis of the vessel wall are the main pathogenic mechanisms behind the disease. The characteristic cutaneous features are porcelain white atrophic papules with a peripheral rim of erythema seen commonly over the trunk, chest, and upper and lower limbs. In Degos disease, cutaneous and systemic manifestations typically do not present simultaneously, with skin lesions often appearing first. Systemic involvement, affecting organs such as the gastrointestinal tract or central nervous system, may develop months or years later. Patients should be closely monitored for potential systemic complications, as these significantly impact prognosis, necessitating multidisciplinary care to ensure early detection and management. The disease carries a poor prognosis because of systemic involvement. Degos disease is extremely rare in children with very few cases being reported in literature. We hereby report a rare case of Degos disease in a five-year-old female child with lesions confined to the skin with a lack of systemic involvement.

Indexed as

cutaneous ulcerdegos diseasefemale childmalignant atrophic papulosisporcelain white scars

Identifiers

PMID39897194
PMCPMC11787949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.